-
1 Comment
CSPC Innovation Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 7.8% below its 200 day moving average.
From a valuation standpoint, the stock is 16.1% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 5.7.
CSPC Innovation Pharmaceutical Co., Ltd's total revenue sank by 4.0% to $285M since the same quarter in the previous year.
Its net income has dropped by 28.8% to $43M since the same quarter in the previous year.
Finally, its free cash flow fell by 22.5% to $50M since the same quarter in the previous year.
Based on the above factors, CSPC Innovation Pharmaceutical Co., Ltd gets an overall score of 1/5.
| ISIN | CNE100003K04 |
|---|---|
| CurrencyCode | CNY |
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| Exchange | SHE |
| Market Cap | 68B |
|---|---|
| PE Ratio | 1207.5 |
| Target Price | 45.2083 |
| Dividend Yield | 0.7% |
| Beta | 0.18 |
CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally. It offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dihydroxyphylline, theobromine, pentoxifylline, doxofylline, and raw enzymes; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC NBP Pharmaceutical Co., Ltd.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300765.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
